Article | May 25, 2017

Important Considerations When Sourcing Reference Products For Biosimilar Studies

Source: Catalent

By Vikram Bali, Comparator & Ancillary Supplies Program Coordinator, Catalent Pharma Solutions

Important Considerations When Sourcing Reference Products For Biosimilar Studies

Pharmaceutical companies face a number of challenges when sourcing comparator compounds for clinical trials, including addressing product lead times, availability, expiry limitations, safety or cost. Learn how clinical trial sponsors can determine the best strategy to meet these challenges.